As Expected, Weak US Sales Cut in Half Ciphergen s Q1 Revenues

genomeweb
360dx

As Expected, Weak US Sales Cut in Half Ciphergen s Q1 Revenues

May 06, 2005

NEW YORK, May 6 (GenomeWeb News) - Ciphergen Biosystems yesterday reported a 50-percent drop in revenues and widened losses for the first quarter of 2005.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

UCL, Congenica, UK Epilepsy Society to Examine Genetic Risk Factors for Sudden Epileptic Death
ASHG: Dutch Nationwide NIPT Implementation Study Sees 42 Percent Uptake After First Year
Histone Acetylome-Wide Study Finds Epigenetic Differences in Alzheimer's Disease
Zeesan Biotech Wins China FDA Approval for HPV Genotyping Assay
GeneATLAS Database Documents Diverse Trait Associations Detected With UK Biobank Data
MRC Holland Gets CE-IVD Mark for Spinal Muscular Atrophy Assay

The Scan

Retirement Moves

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura Dies

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

This Week in PLOS

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Shuffle at IBM Watson Health

Stat News reports that the head of IBM Watson Health is leaving her post.

Main menu